SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001362310-07-002350
Filing Date
2007-10-02
Accepted
2007-10-02 06:01:18
Documents
4
Period of Report
2007-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c71278e8vk.htm 8-K 12101
2 EXHIBIT 10.1 c71278exv10w1.htm EX-10.1 18207
3 EXHIBIT 99.1 c71278exv99w1.htm EX-99.1 7042
4 GRAPHIC c71278c7127801.gif GRAPHIC 7410
  Complete submission text file 0001362310-07-002350.txt   49413
Mailing Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011
Business Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 071147470
SIC: 2834 Pharmaceutical Preparations